MediPharm Labs
(TSX) LABS
MediPharm Labs Financials at a Glance
Market Cap
$27.35M
Revenue (TTM)
$45.12M
Net Income (TTM)
$8.27M
EPS (TTM)
$-0.02
P/E Ratio
-3.30
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.07
Volume
51,900
Open
$0.07
Price
$0.07
Volume
51,900
Open
$0.07
Previous Close
$0.07
Daily Range
$0.07 - $0.07
52-Week Range
$0.06 - $0.11
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.07
Volume
51,900
Open
$0.07
Previous Close
$0.07
Daily Range
$0.07 - $0.07
52-Week Range
$0.06 - $0.11
LABS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MediPharm Labs
Industry
Pharmaceuticals
Sector
Health CareEmployees
127
CEO
David A. Pidduck, EMBA
Website
www.medipharmlabs.comHeadquarters
Barrie, ON L4N 2L1, CA
LABS Financials
Key Financial Metrics (TTM)
Gross Margin
31%
Operating Margin
-19%
Net Income Margin
-18%
Return on Equity
-21%
Return on Capital
-23%
Return on Assets
-18%
Earnings Yield
-30.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$27.35M
Shares Outstanding
420.75M
Volume
51.90K
Short Interest
0.00%
Avg. Volume
162.44K
Financials (TTM)
Gross Profit
$13.97M
Operating Income
$8.41M
EBITDA
$6.54M
Operating Cash Flow
$5.50M
Capital Expenditure
$100.00K
Free Cash Flow
$5.60M
Cash & ST Invst.
$10.81M
Total Debt
$201.00K
MediPharm Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.06M
-8.1%
Gross Profit
$3.89M
+14.6%
Gross Margin
35.20%
N/A
Market Cap
$27.35M
N/A
Market Cap/Employee
$169.87K
N/A
Employees
161
N/A
Net Income
$1.97M
-14.0%
EBITDA
$1.55M
-35.8%
Quarterly Fundamentals
Net Cash
$10.61M
-6.2%
Accounts Receivable
$7.53M
+0.2%
Inventory
$8.02M
-7.9%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$201.00K
-40.4%
Return on Assets
-18.07%
N/A
Return on Invested Capital
-23.48%
N/A
Free Cash Flow
$435.00K
+139.2%
Operating Cash Flow
$435.00K
+140.8%